Ocrevus will help with multiple sclerosis
The FDA-approved new drug for the treatment of multiple sclerosis "Okrevus" is produced by Genentech, owned by pharmaceutical giant Roche.
30.03.2017The FDA-approved new drug for the treatment of multiple sclerosis "Okrevus" is produced by Genentech, owned by pharmaceutical giant Roche.
30.03.2017Genetically modified wormwood synthesizes twice as much artemisinin, the main and most effective component of malaria drugs.
29.03.2017So far, the model can only simulate the synthesis of hormones within the monthly cycle, but not the movement of eggs (they mature, but do not move anywhere), and especially not pregnancy.
29.03.2017Veronika Skvortsova said that by 2020, medical technologies will be publicly available in Russia, which even in foreign practice will begin to be implemented in 10-15 years.
29.03.2017Nanoparticles can be compared to a sledgehammer for bacteria: they have no defense mechanisms against nanoparticles, and even in theory they cannot develop resistance.
29.03.2017In a series of experiments, scientists have grown human cardiomyocytes suitable for transplantation in cellulose capillaries of spinach leaves, purified from plant tissues.
29.03.2017Russian scientists have successfully tested spongy bone implants based on ultrahigh molecular weight polyethylene (UHMWPE): 100% of the implanted samples have successfully taken root.
28.03.2017Clinical studies have shown that 8 out of 15 men with erectile dysfunction were able to have sex six months after a single injection of stem cells.
28.03.2017While some scientists are developing ways to deliver humans to Mars, others are studying the possible dangers that await astronauts and colonists on their way to the goal.
28.03.2017Previous authors have identified approximately 20 to 30 genetic syndromes that cause obesity. A new study has revealed the existence of 79 such syndromes.
28.03.2017PricewaterhouseCoopers and the Russian Venture Company present the sixth annual review of the Russian venture industry "MoneyTreeTM: Navigator of the Venture Market" for 2016.
28.03.2017The above discussion contains up-to-date information on the wide applicability of stem cells and induced pluripotent stem cells in the field of neurodegeneration.
27.03.2017Biologists have come up with a way to produce viable red blood cells in quantities suitable for clinical use. To do this, they created an "immortal" line of progenitor cells.
27.03.2017In a completely different way than in the material "Dangerous Copying" just published on our website, the retold article about random mutations and the risk of cancer.
27.03.2017DNA can be detected not only inside cells, but also outside – such molecules are called extracellular DNA (vcDNA). They exist by themselves and affect the surrounding cells.
27.03.2017Researchers from Johns Hopkins University claim that the main cause of cancer are mutations caused by errors in copying DNA during stem cell division.
27.03.2017A new approach that will lead to a complete cure for HIV infection can be developed based on the results obtained by a group of French scientists.
27.03.2017The modified natural protein eliminated the toxic effects of chemotherapy and physiological signs of aging in mice by targeted removal of aged cells.
24.03.2017Biologist Georgy Bazykin – about experimental evolutionary biology, HIV, mutations of the influenza virus and how to determine the strain of the influenza virus to create a vaccine.
24.03.2017Chemists from the Technological University of Munich have developed a new modification of the DNA origami technique, in which protein fragments act as paper clips.
24.03.2017You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.